Immunosuppressive therapy in primary glomerulonephritis (pros).
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy*; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D013256:Steroids; D002699:Chlorambucil; D004176:Dipyridamole; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D006493:Heparin; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone; D007213:Indomethacin